Your Location：
Home >
Browse articles >
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
COMMENTARY | Updated：2025-12-13
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
- “In the field of xxx, expert xx has made significant progress. They established the xx system/explored the xx topic/verified the xx conjecture, offering solutions to tackle xx problems and paving the way for future research in xx.”
- Military Medical Research Vol. 11, Issue 6, Pages: 963-964(2024)
DOI： 10.1186/s40779-023-00507-2
Scan QR Code
AI Introduction
Full Text(HTML)
References
Publication Info
Metrics
27
Views
21
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
The emerging role of ferroptosis in the pathological development and progression of sepsis
Hypoxia: a critical pathophysiological driver in respiratory inflammatory diseases
Healing of tendon-related diseases: insights from macrophage regulation
Frostbite: diagnosis, treatment, prognosis, and future directions
Related Author
Shao-Yu Liu
Shao-Kang Xu
Jing-Li Gao
Xiao-Ke Kong
Jian Shi
Ya Miao
Yi-Ting Tang
Bin Zhao
Related Institution
Department of Cardiology, Kailuan General Hospital
Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University
Department of Critical Care Medicine and Hematology, the Third Xiangya Hospital, Central South University
Department of Intensive Medicine, Kailuan General Hospital
National Clinical Research Center for Endocrine and Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University
